U.S. Bancorp USB has been analyzed by 17 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 8 | 6 | 0 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 2 | 3 | 0 | 0 | 0 |
| 2M Ago | 1 | 1 | 1 | 0 | 0 |
| 3M Ago | 0 | 4 | 4 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $58.24, a high estimate of $65.00, and a low estimate of $51.00. Observing a 7.71% increase, the current average has risen from the previous average price target of $54.07.
Understanding Analyst Ratings: A Comprehensive Breakdown
In examining recent analyst actions, we gain insights into how financial experts perceive U.S. Bancorp. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| John McDonald | Truist Securities | Announces | Hold | $54.00 | - |
| Jason Goldberg | Barclays | Raises | Overweight | $61.00 | $57.00 |
| Chris Kotowski | Oppenheimer | Lowers | Outperform | $62.00 | $66.00 |
| Peter Winter | DA Davidson | Raises | Buy | $60.00 | $58.00 |
| Michael Rose | Raymond James | Announces | Outperform | $57.00 | - |
| David Rochester | Compass Point | Raises | Buy | $60.00 | $49.00 |
| Scott Siefers | Piper Sandler | Raises | Neutral | $58.00 | $52.00 |
| Keith Horowitz | Citigroup | Raises | Buy | $65.00 | $49.00 |
| Mike Mayo | Wells Fargo | Raises | Overweight | $62.00 | $60.00 |
| Chris Kotowski | Oppenheimer | Raises | Outperform | $64.00 | $59.00 |
| Vijay Kumar | Evercore ISI Group | Raises | In-Line | $54.00 | $51.00 |
| Matt O'Connor | Deutsche Bank | Maintains | Hold | $51.00 | $51.00 |
| Peter Winter | DA Davidson | Raises | Neutral | $54.00 | $49.00 |
| Mike Mayo | Wells Fargo | Raises | Overweight | $60.00 | $52.00 |
| Jason Goldberg | Barclays | Raises | Overweight | $57.00 | $52.00 |
| Chris Kotowski | Oppenheimer | Raises | Outperform | $59.00 | $57.00 |
| Terry McEvoy | Stephens & Co. | Raises | Equal-Weight | $52.00 | $49.00 |
Key Insights:
- Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to U.S. Bancorp. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of U.S. Bancorp compared to the broader market.
- Price Targets: Delving into movements, analysts provide estimates for the future value of U.S. Bancorp's stock. This analysis reveals shifts in analysts' expectations over time.
For valuable insights into U.S. Bancorp's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
Stay up to date on U.S. Bancorp analyst ratings.
About U.S. Bancorp
With assets of around $680 billion, U.S. Bancorp is one of the largest regional banks in the us with its footprint in 26 states. The bank's branch network is mostly in the midwestern and western markets. U.S. Bancorp has a comprehensive product set, with offerings in retail and commercial banking, credit cards, mortgages, payment services, trust, and wealth services.
Key Indicators: U.S. Bancorp's Financial Health
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Negative Revenue Trend: Examining U.S. Bancorp's financials over 3 months reveals challenges. As of 30 September, 2024, the company experienced a decline of approximately -2.39% in revenue growth, reflecting a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.
Net Margin: U.S. Bancorp's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 23.43%, the company may face hurdles in effective cost management.
Return on Equity (ROE): U.S. Bancorp's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 3.15%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): U.S. Bancorp's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.23%, the company may face hurdles in achieving optimal financial returns.
Debt Management: U.S. Bancorp's debt-to-equity ratio is below the industry average. With a ratio of 1.51, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
The Core of Analyst Ratings: What Every Investor Should Know
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
